Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Repeat hepatectomy for cancer

D Elias1, P Lasser, J M Hoang

  • 1Oncology, Digestive and Hepatic Surgery Unit, Institut Gustave Roussy, Centre Anticancéreux, Villejuif, France.

The British Journal of Surgery
|December 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

On the backseat: Analyzing motorcycle passenger injuries in children.

American journal of surgery·2025
Same author

Urinary incontinence and female genital lichen sclerosus.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

Reply to 'EuroGuiderm Guideline on lichen sclerosus-introduction into lichen sclerosus'.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

Reply to 'EuroGuiderm guideline on lichen sclerosus-Treatment of lichen sclerosus'.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

European Myeloma Network Group review and consensus statement on primary plasma cell leukemia.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Response adaptive salvage treatment with daratumumab-lenalidomide-dexamethasone for newly diagnosed transplant-eligible multiple myeloma patients failing front-line bortezomib-based induction therapy-ALLG MM21.

British journal of haematology·2024
Same journal

Trimester-Specific Safety of Laparoscopic versus Open Abdominal Surgery During Pregnancy: A Systematic Review and Meta-analysis.

The British journal of surgery·2026
Same journal

The Gut Microbiome in Surgical Oncology: Mechanisms, Perioperative Outcomes, and Therapeutic Opportunities.

The British journal of surgery·2026
Same journal

Patient-led, home-based follow-up for colorectal cancer: the DISTANCE multicentre stepped-wedge cluster-randomised trial.

The British journal of surgery·2026
Same journal

Correction to: Reduced secretory efficiency in parathyroid carcinoma: diagnostic value of the PTH-to-tumour-volume ratio.

The British journal of surgery·2026
Same journal

Global disparities in hepatocellular carcinoma outcomes: multicentre study.

The British journal of surgery·2026
Same journal

Surgical Outcomes from Nationwide Implementation of the International Best-Practice for Locally Advanced Pancreatic Cancer (PREOPANC-4) study.

The British journal of surgery·2026
See all related articles

Repeat hepatectomy for liver cancer recurrence is a safe procedure with encouraging survival rates. However, technical challenges exist, and indications require further clarification for optimal patient outcomes.

Area of Science:

  • Hepatobiliary Surgery
  • Surgical Oncology
  • Gastroenterology

Background:

  • Repeat hepatectomies are performed for recurrent liver cancer.
  • Understanding the outcomes and challenges of repeat liver resections is crucial.

Purpose of the Study:

  • To evaluate the safety, morbidity, and survival rates of repeat hepatectomies for cancer.
  • To identify technical difficulties and factors influencing postoperative complications.

Main Methods:

  • Retrospective analysis of 279 hepatectomies, including 46 repeat operations.
  • Data collection on patient demographics, primary tumor type, recurrence patterns, operative details, complications, and survival.

Main Results:

  • Hospital mortality was 2%, with a 32% overall morbidity rate.

Related Experiment Videos

  • Hemorrhagic complications were higher after repeat hepatectomy (12% vs. 5%).
  • Crude and recurrence-free survival rates at 3 years were 47% and 33%, respectively, with lower rates for colorectal cancer.

    • Conclusions:

    • Repeat hepatectomy is a safe surgical option for liver cancer recurrence.
    • Technical challenges include re-exposure, parenchymal modifications, and altered anatomy.
    • Further clarification of indications for repeat hepatectomy is needed.